Drugs Made In America Acquisition Corp. logo

Drugs Made In America Acquisition Corp. (DMAAR)

Market Closed
27 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
0. 16
-0
-2.439%
$
345.02M Market Cap
- P/E Ratio
- Div Yield
75,388 Volume
- Eps
$ 0.16
Previous Close
Investors:
Add Transaction
Day Range
0.15 0.17
Year Range
0.04 0.24
Want to track DMAAR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Drugs Made In America Acquisition Corp. Investors

Name Quantity Cost Value Profit ($) Gain (%)
SK
Steven Katznelson Radcliffe Capital Management LP
231,551 $50,339.19 $20,909.06 -$29,430.13 -58.46%
Bulldog Investors
Bulldog Investors Bulldog Investors LLP
43,364 $9,427.33 $3,915.77 -$5,511.56 -58.46%
BO
Brian Oliveira Clear Street Group Inc.
711,917 $141,193.3 $64,286.11 -$76,907.19 -54.47%